Provided by Tiger Trade Technology Pte. Ltd.

GRAND PHARMA

5.150
+0.0500.98%
Volume:5.68M
Turnover:29.36M
Market Cap:18.28B
PE:14.53
High:5.290
Open:5.070
Low:5.070
Close:5.100
52wk High:9.559
52wk Low:4.530
Shares:3.55B
HK Float Shares:3.55B
Volume Ratio:0.76
T/O Rate:0.16%
Dividend:0.17
Dividend Rate:3.28%
EPS(LYR):0.354
ROE:7.38%
ROA:4.23%
PB:1.07
PE(LYR):14.53
PS:1.49

Loading ...

Grand Pharmaceutical Group announces annual general meeting

Reuters
·
Apr 29

Grand Pharmaceutical Announces Transition to Electronic Dissemination of Corporate Communications

Bulletin Express
·
Apr 29

Chairman Tang Weikun Acquires 50,000 Shares of Grand Pharma at HK$6.47 Each

Stock News
·
Apr 22

Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After Positive DOORwaY90 Liver Cancer Trial Results

Simply Wall St.
·
Apr 22

Grand Pharma Shares Surge Over 4% as Breakthrough Nuclear Medicine SIR-Spheres® Yttrium-90 Microspheres Hit New Milestone

Deep News
·
Apr 14

GRAND PHARMA's Yttrium-90 Microsphere Injection Achieves Endpoints in US Liver Cancer Trial, Accelerating Global Sales

Stock News
·
Apr 13

BRIEF-Grand Pharmaceutical Says SIR-Spheres Y-90 Microsphere Injection US HCC Study Reaches Clinical Endpoint

Reuters
·
Apr 13

Grand Pharma says US DOORwaY90 trial of SIR-Spheres Y-90 in HCC hits endpoint

Reuters
·
Apr 13

Grand Pharmaceutical - Sir-Spheres Y-90 Microsphere Injection US Hcc Study Reaches Clinical Endpoint

THOMSON REUTERS
·
Apr 13

EXCLUSIVE-Chinese business hired lobbying firm with ties to Don Jr, then scored a win in Washington

Reuters
·
Apr 09

Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After China Drug Approvals And Earnings Update

Simply Wall St.
·
Apr 06

Why Grand Pharmaceutical Group (SEHK:512) Is Up 9.7% After Mixed 2025 Results And New Drug Milestones

Simply Wall St.
·
Apr 03

Stock Track | Grand Pharma Soars 5.01% Intraday on Chairman's Share Purchase Confidence

Stock Track
·
Mar 30

Board Chairman of Grand Pharma Purchases 60,000 Shares at HK$6.5 Each

Deep News
·
Mar 30

A Look At Grand Pharmaceutical Group (SEHK:512) Valuation After 2025 Earnings Reset And New Ophthalmic Drug Approval

Simply Wall St.
·
Mar 29

Chairman Tang Weikun Increases Stake in GRAND PHARMA with 60,000 Shares at HK$6.5 Each

Stock News
·
Mar 27

Nuclear Medicine Leadership and Innovation Breakthroughs: GRAND PHARMA (00512) Accelerates Value Realization in 2025

Stock News
·
Mar 27

BRIEF-Grand Pharmaceutical Group Posts FY Revenue HKD 12,283.27 Million

Reuters
·
Mar 26

Grand Pharma Declares HKD 0.169 Final Dividend for FY 2025; Payment Slated for 30 June 2026

Bulletin Express
·
Mar 26

GRAND PHARMA Reports Record High Contribution from Innovative Products; Nuclear Medicine Segment Revenue Surges Nearly 15-Fold in Four Years

Stock News
·
Mar 26